教条 发表于 2025-3-21 17:25:09

书目名称Cannabinoids and Neuropsychiatric Disorders影响因子(影响力)<br>        http://impactfactor.cn/2024/if/?ISSN=BK0221311<br><br>        <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders影响因子(影响力)学科排名<br>        http://impactfactor.cn/2024/ifr/?ISSN=BK0221311<br><br>        <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders网络公开度<br>        http://impactfactor.cn/2024/at/?ISSN=BK0221311<br><br>        <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders网络公开度学科排名<br>        http://impactfactor.cn/2024/atr/?ISSN=BK0221311<br><br>        <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders被引频次<br>        http://impactfactor.cn/2024/tc/?ISSN=BK0221311<br><br>        <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders被引频次学科排名<br>        http://impactfactor.cn/2024/tcr/?ISSN=BK0221311<br><br>        <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders年度引用<br>        http://impactfactor.cn/2024/ii/?ISSN=BK0221311<br><br>        <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders年度引用学科排名<br>        http://impactfactor.cn/2024/iir/?ISSN=BK0221311<br><br>        <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders读者反馈<br>        http://impactfactor.cn/2024/5y/?ISSN=BK0221311<br><br>        <br><br>书目名称Cannabinoids and Neuropsychiatric Disorders读者反馈学科排名<br>        http://impactfactor.cn/2024/5yr/?ISSN=BK0221311<br><br>        <br><br>

著名 发表于 2025-3-22 00:15:21

http://reply.papertrans.cn/23/2214/221311/221311_2.png

Synthesize 发表于 2025-3-22 01:27:46

http://reply.papertrans.cn/23/2214/221311/221311_3.png

谆谆教诲 发表于 2025-3-22 05:38:06

http://reply.papertrans.cn/23/2214/221311/221311_4.png

resilience 发表于 2025-3-22 09:57:45

http://reply.papertrans.cn/23/2214/221311/221311_5.png

locus-ceruleus 发表于 2025-3-22 14:16:52

http://reply.papertrans.cn/23/2214/221311/221311_6.png

locus-ceruleus 发表于 2025-3-22 17:04:50

http://reply.papertrans.cn/23/2214/221311/221311_7.png

DAFT 发表于 2025-3-22 21:33:03

https://doi.org/10.1007/978-3-662-64129-3n. There is preclinical evidence that alteration in the endocannabinoid system could potentially benefit patients suffering from depression. However, the issue of using cannabis as an anti-depressant is at an early stage of examination and there is little evidence to support it. Finally, there has b

VEIL 发表于 2025-3-23 04:39:13

http://reply.papertrans.cn/23/2214/221311/221311_9.png

Barter 发表于 2025-3-23 07:24:19

Keeley C. Harmon,Joe Ann Clark,Vicki Morand seizure conditions. Clinical trials are ongoing for other forms of epilepsy and refractory seizures associated with infantile spasms, tuberous sclerosis, and Rett syndrome. Overall, adjunct CBD has been found to be generally safe and effective for treatment-resistant seizures in children with seve
页: [1] 2 3 4 5
查看完整版本: Titlebook: Cannabinoids and Neuropsychiatric Disorders; Eric Murillo-Rodriguez,S. R. Pandi-Perumal,Jaime M Book 2021 The Editor(s) (if applicable) an